Global Lateral Flow Immunoassays Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Lateral Flow Immunoassays Market Research Report 2024
Lateral flow immunoassays are easy to use. The user simply needs to dip the sample pad into the liquid they want to test and then lay the test flat or apply the sample directly to the cassette. If the test is positive, a colored or fluorescent line will show up on the test along with a control line. If the test is negative, only the control line will be present. For many years, women with no medical training have successfully used this kind of test to detect pregnancy or ovulation at home.
According to MRAResearch’s new survey, global Lateral Flow Immunoassays market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lateral Flow Immunoassays market research.
Key companies engaged in the Lateral Flow Immunoassays industry include Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc. and QIAGEN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Lateral Flow Immunoassays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lateral Flow Immunoassays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lateral Flow Immunoassays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott Laboratories
F. Hoffmann-La Roche AG
Danaher Corporation
Siemens AG
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
QIAGEN
PerkinElmer Inc.
Hologic Inc.
Quidel Corporation
Merck KGaA
Segment by Type
Kits & Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers
Hospitals and Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lateral Flow Immunoassays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Lateral Flow Immunoassays market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lateral Flow Immunoassays market research.
Key companies engaged in the Lateral Flow Immunoassays industry include Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Siemens AG, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc. and QIAGEN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Lateral Flow Immunoassays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lateral Flow Immunoassays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lateral Flow Immunoassays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
F. Hoffmann-La Roche AG
Danaher Corporation
Siemens AG
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
QIAGEN
PerkinElmer Inc.
Hologic Inc.
Quidel Corporation
Merck KGaA
Segment by Type
Kits & Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lateral Flow Immunoassays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source